« Back
Home /
Durvalumab

Durvalumab

Item no.	TMO-T11126-5mg
Manufacturer	TargetMol
CASRN	1428935-60-7
Amount	5 mg
Quantity options	100 mg 1 mg 200mg 25 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	MEDI 4736
Shipping condition	Cool pack
Available
Manufacturer - Targets	PD-1/PD-L1
Shipping Temperature	cool pack
Storage Conditions	-20°
Target names or alias	MEDI 4736
Description	Durvalumab (MEDI 4736) is a humanized monoclonal antibody targeting PD-L1. It can block the interaction of PD-L1 with PD-1 and CD80, with IC50 values of 0.1 and 0.04 nM, respectively. Durvalumab is often used in combination with platinum-based compounds for the treatment of non-small cell lung cancer and advanced hepatocellular carcinoma cells.
Pathways	Immunology/Inflammation\|\|\|Apoptosis\|\|\|Cell Cycle/Checkpoint

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T11126-5mg-datasheet.pdf

TMO-T11126-5mg-safety-datasheet.pdf